Clinical evaluation of in vitro chemosensitivity testing: The example of uveal melanoma

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 7, 2004, Pages 395-399

  Terheyden, P ^a   Brocker E B ^a   Becker, J C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chemosensitivity testing; Choroidal melanoma; Melanoma; Metastases; Polychemotherapy

Indexed keywords

GEMCITABINE; TREOSULFAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSENSITIVITY; CILIARY BODY TUMOR; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL TIME;

EID: 3843070956     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0569-4     Document Type: Article

References (15)

1. Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB (2002) Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 87:840-845
2. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS (1995) Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 76:1665-1670
3. Cortazar P and Johnson BE (1999) Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 17:1625-1631
4. Cree IA (2003) Chemosensitivity testing as an aid to anti-cancer drug and regimen development. Recent Results Cancer Res 161:119-125
5. Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S (2003) A prognostic model and staging for metastastic uveal melanoma. Cancer 97:465-475
6. Frankfurt OS, Krishan A (2003) Apoptosis enzyme-linked immunosorbent assay distinguishes anticancer drugs from toxic chemicals and predicts drug synergism. Chem Biol Interact 145:89-99
7. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Van Der Does-Van Den Berg A (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 90:2723-2729
8. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S (1993) Prognosis and treatment of disseminated uveal melanoma. Cancer 72:2219-2223
9. Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L (1997) Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15:2589-2595
10. McLeod HL, Murray GI, Mollison J, McKay J, Cassidy J (1999) Selection of markers to predict tumour response or survival: description of a novel approach. Eur J Cancer 35:1650-1652
11. McNamara M, Clynes M, Dunne B, NicAmhlaoibh R, Lee WR, Barnes C, Kennedy SM (1996) Multidrug resistance in ocular melanoma. Br J Ophthalmol 80:1009-1012
12. Neale MH, Myatt NE, Khoury GG, et al (2001) Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 11:601-609
13. Pföhler C, Cree IA, Ugurel S, Kuwert C, Haass N, Neuber K, Hengge U, Corrie PG, Zutt M, Tilgen W, Reinhold U (2003) Treosulfan and gemcitabine in metastastic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs 14:337-340
14. Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 100:7737-7742
15. Shields JA, Shields CL, DePotter O, Singh AD (1996) Diagnosis and treatment of uveal melanoma. Semin Oncol 23:763-767